External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Roche and Genentech at

ECCO 2025

February 19 - February 22

Berlin, Germany

ecco-ibd.eu

Add to calendar

Medical Materials

Agenda

Coming soon

08:06 AM

Duration 6mins Hall: A8

RO7790121 shows early and rapid symptomatic remission in the treatment of moderately to severely active Ulcerative Colitis - Findings from the phase 2b TUSCANY-2 trial

Allegretti JR, Yarur A, Feagan B, Danese S, Schreiber S, Peyrin-Biroulet L, Ha C, Kierkus J, Leong RW, Vincent MS, Banerjee A, Chandra DE, Peeva E, Neelakantan S, Hung KE, Bojic D, Lasch K, Schiffman C, V Jairath

Inflammatory Disease | Inflammatory Bowel Disease

Add to calendar

09:35 AM

Duration 20mins Berlin, Germany

New frontiers in inflammatory bowel disease TL1A inhibition – from mode of action to clinical application

Dr Remo Panaccione, Dr Jean-Frédéric Colombel

Inflammatory Disease | Inflammatory Bowel Disease

Add to calendar

10:50 AM

Duration 10mins Hall: A8

Treatment with RO7790121 induces and maintains histologic and histologic-endoscopic improvement and remission in moderately to severely active Ulcerative Colitis - Results from TUSCANY-2

Jairath V, Allegretti JR, Yarur A, Danese S, Schreiber S, Peyrin-Biroulet L, Kierkus J, Leong RW, Vincent MS, Banerjee A, Chandra DE, Peeva E, Neelakantan S, Hung KE, Bojic D, Lasch K, Schiffman C, Feagan B

Inflammatory Disease | Inflammatory Bowel Disease

Add to calendar

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.